• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Movers For July 12, 2022

    7/12/22 5:21:08 PM ET
    $ACB
    $MBII
    $NINE
    $OGI
    Medicinal Chemicals and Botanical Products
    Health Care
    Major Chemicals
    Basic Industries
    Get the next $ACB alert in real time by email

    GAINERS:

    • MariMed (OTC:MRMD) shares closed up 11.40% at $0.64
    • Cansortium (OTC:CNTMF) shares closed up 8.11% at $0.20
    • RIV Capital (OTC:CNPOF) shares closed up 7.52% at $0.47
    • EnWave (OTC:NWVCF) shares closed up 7.31% at $0.50
    • BioHarvest Sciences (OTC:CNVCF) shares closed up 7.28% at $0.20
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 4.90% at $1.07
    • Urban-gro (NASDAQ:UGRO) shares closed up 4.73% at $5.53
    • TerrAscend (OTC:TRSSF) shares closed up 4.52% at $2.31
    • World Acceptance (NASDAQ:WRLD) shares closed up 3.33% at $105.85
    • Aurora Cannabis (NASDAQ:ACB) shares closed up 3.17% at $1.30

    LOSERS:

    • Marrone Bio Innovations (NASDAQ:MBII) shares closed down 20.19% at $0.80
    • Nine Energy Service (NYSE:NINE) shares closed down 9.41% at $2.31
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 6.61% at $0.05
    • Charlottes Web Holdings (OTC:CWBHF) shares closed down 6.11% at $0.43

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $MBII
    $NINE
    $OGI

    CompanyDatePrice TargetRatingAnalyst
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    World Acceptance Corporation
    $WRLD
    11/13/2024$10.00Equal-Weight
    Stephens
    Organigram Global Inc.
    $OGI
    7/17/2024Speculative Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    4/15/2024Neutral → Buy
    Alliance Global Partners
    Aurora Cannabis Inc.
    $ACB
    2/9/2024Hold → Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/13/2023Hold → Buy
    Stifel
    More analyst ratings

    $ACB
    $MBII
    $NINE
    $OGI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Monroe William bought $1,159,545 worth of shares (960,000 units at $1.21), increasing direct ownership by 25% to 4,863,000 units (SEC Form 4)

    4/A - Nine Energy Service, Inc. (0001532286) (Issuer)

    2/11/25 4:46:51 PM ET
    $NINE
    Oilfield Services/Equipment
    Energy

    Amendment: Large owner Monroe William bought $744,019 worth of shares (470,362 units at $1.58), increasing direct ownership by 14% to 3,903,000 units (SEC Form 4)

    4/A - Nine Energy Service, Inc. (0001532286) (Issuer)

    2/11/25 4:45:14 PM ET
    $NINE
    Oilfield Services/Equipment
    Energy

    Large owner Monroe William bought $1,159,545 worth of shares (960,000 units at $1.21), increasing direct ownership by 25% to 4,860,000 units (SEC Form 4)

    4 - Nine Energy Service, Inc. (0001532286) (Issuer)

    11/22/24 6:33:50 PM ET
    $NINE
    Oilfield Services/Equipment
    Energy

    $ACB
    $MBII
    $NINE
    $OGI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand

    NASDAQ | TSX: ACB Launch reinforces Aurora's leadership position across key international markets  EDMONTON, AB, Feb. 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is expanding its Aurora® medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality, and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and healthcare professionals in the region, reflecting Aurora's strategic focus on long-term global growth.

    2/11/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program

    NASDAQ | TSX: ACB EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has filed a prospectus supplement establishing a new at-the-market offering program (the "ATM Program") that allows the Company to issue and sell up to U.S.$100 million of common shares in the capital of the Company (the "Common Shares") from treasury to the public, from time to time, at the Company's discretion. The Company intends to use the net proceeds from th

    2/4/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $MBII
    $NINE
    $OGI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Calmes John L Jr sold $149,213 worth of shares (1,000 units at $149.21) and covered exercise/tax liability with 3,061 shares, decreasing direct ownership by 7% to 51,334 units (SEC Form 4)

    4 - WORLD ACCEPTANCE CORP (0000108385) (Issuer)

    12/19/25 1:39:50 PM ET
    $WRLD
    Finance: Consumer Services
    Finance

    SVP, Human Resources Caulder Alice Lindsay covered exercise/tax liability with 1,224 shares, decreasing direct ownership by 7% to 15,291 units (SEC Form 4)

    4 - WORLD ACCEPTANCE CORP (0000108385) (Issuer)

    12/19/25 1:38:23 PM ET
    $WRLD
    Finance: Consumer Services
    Finance

    SVP, Information Technology Childers Jason E. covered exercise/tax liability with 1,224 shares, decreasing direct ownership by 8% to 14,799 units (SEC Form 4)

    4 - WORLD ACCEPTANCE CORP (0000108385) (Issuer)

    12/19/25 1:38:06 PM ET
    $WRLD
    Finance: Consumer Services
    Finance

    $ACB
    $MBII
    $NINE
    $OGI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Aurora Cannabis

    Canaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy

    1/27/26 9:29:20 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    TD Cowen initiated coverage on Aurora Cannabis

    TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy

    12/11/24 10:35:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $MBII
    $NINE
    $OGI
    SEC Filings

    View All

    World Acceptance Corporation filed SEC Form 8-K: Other Events

    8-K - WORLD ACCEPTANCE CORP (0000108385) (Filer)

    2/11/26 2:33:49 PM ET
    $WRLD
    Finance: Consumer Services
    Finance

    SEC Form 10-Q filed by urban-gro Inc.

    10-Q - urban-gro, Inc. (0001706524) (Filer)

    2/10/26 3:34:03 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/10/26 7:41:44 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $MBII
    $NINE
    $OGI
    Leadership Updates

    Live Leadership Updates

    View All

    Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

    NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries. "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicated

    12/8/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    World Acceptance Corporation Announces the Retirement of Chief Branch Operations Officer D. Clinton Dyer

    World Acceptance Corporation (NASDAQ:WRLD) ("World Acceptance" or "the Company") today announced the planned retirement of D. Clinton Dyer, the Company's Executive Vice President and Chief Branch Operations Officer, following an extraordinary 30-year career with the organization. During his three decades with World Acceptance, Mr. Dyer helped shape and strengthen the Company's branch operations through steadfast leadership, deep operational knowledge, and a genuine commitment to the customers and communities the Company serves. "Clint has been a pillar of the Company for thirty years," said Chad Prashad, the Company's President and Chief Executive Officer. "His leadership, dedication, and

    12/4/25 7:30:00 AM ET
    $WRLD
    Finance: Consumer Services
    Finance

    Aurora Announces Distribution Partnership with Leafio Australia

    The collaboration will improve medical cannabis access and better serve patients across Australia NASDAQ | TSX: ACB EDMONTON, AB, Dec. 2, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today announced the company's wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to trusted, safe, and effective medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve as a wholesaler of Aurora's leading portfoli

    12/2/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $MBII
    $NINE
    $OGI
    Financials

    Live finance-specific insights

    View All

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aurora Cannabis Announces Fiscal 2026 Third Quarter Results

    NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.

    2/4/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $MBII
    $NINE
    $OGI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ACB
    $MBII
    $NINE
    $OGI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by World Acceptance Corporation

    SC 13G/A - WORLD ACCEPTANCE CORP (0000108385) (Subject)

    11/14/24 9:39:10 AM ET
    $WRLD
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    9/3/24 9:30:26 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care